IPCALAB

Ipca Laboratories Share Price

 

 

Invest in Ipca Laboratories with 3.22X leverage

Invest with MTF

Performance

  • Low
  • ₹1,305
  • High
  • ₹1,548
  • 52 Week Low
  • ₹1,168
  • 52 Week High
  • ₹1,756
  • Open Price₹1,310
  • Previous Close₹1,302
  • Volume4,131,703

Investment Returns

  • Over 1 Month + 14.05%
  • Over 3 Month + 8.32%
  • Over 6 Month + 5.22%
  • Over 1 Year -3.71%

Smart Investing Starts Here Start SIP with Ipca Laboratories for Steady Growth!

Invest Now

Ipca Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 45.1
  • PEG Ratio
  • 1.7
  • Market Cap Cr
  • 37,538
  • P/B Ratio
  • 5.4
  • Average True Range
  • 54.64
  • EPS
  • 35.26
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -3.07
  • RSI
  • 70.21
  • MFI
  • 87.22

Ipca Laboratories Financials

Ipca Laboratories Technicals

EMA & SMA

Current Price
₹1,479.60
+ 177.6 (13.64%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,326.47
  • 50 Day
  • ₹1,333.69
  • 100 Day
  • ₹1,357.65
  • 200 Day
  • ₹1,379.35

Resistance and Support

1444.2 Pivot Speed
  • R3 1,826.40
  • R2 1,687.20
  • R1 1,583.40
  • S1 1,340.40
  • S2 1,201.20
  • S3 1,097.40

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ipca Laboratories Ltd. is a global pharmaceutical company, producing over 350 formulations and 80 APIs. Operating in 120+ countries, it leads in therapeutic areas like pain, rheumatology, and antimalarials, with fully-automated facilities approved by global regulatory bodies.

Ipca Laboratories has an operating revenue of Rs. 9,357.41 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 13% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 25% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ipca Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-29 Audited Results & Final Dividend
2025-02-13 Quarterly Results
2024-11-14 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-08-05 FINAL Rs.2.00 per share(200%)Final Dividend
2024-11-25 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2023-11-22 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2022-11-23 INTERIM Rs.4.00 per share(400%)Interim Dividend
2021-11-23 INTERIM Rs.8.00 per share(400%)Interim Dividend
View Ipca Laboratories Dividend History Arrow
Date Purpose Remarks
2022-01-11 Split Rs.0.00 split from Rs. 2/- to Re. 1/-.

Ipca Laboratories F&O

Ipca Laboratories Shareholding Pattern

44.72%
30.04%
5.99%
10.42%
0%
6.55%
2.28%

About Ipca Laboratories

  • NSE Symbol
  • IPCALAB
  • BSE Symbol
  • 524494
  • Managing Director & CFO
  • Mr. Ajit Kumar Jain
  • ISIN
  • INE571A01038

Similar Stocks to Ipca Laboratories

Ipca Laboratories FAQs

Ipca Laboratories share price is ₹1,479 As on 16 November, 2025 | 10:44

The Market Cap of Ipca Laboratories is ₹37538.1 Cr As on 16 November, 2025 | 10:44

The P/E ratio of Ipca Laboratories is 45.1 As on 16 November, 2025 | 10:44

The PB ratio of Ipca Laboratories is 5.4 As on 16 November, 2025 | 10:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23